These final results, together with a earlier report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 help the principle of focusing on ACKR3 as a novel strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-linked Ailments. By ticking this https://josephk592jjf9.mybuzzblog.com/profile